Bersanelli, M.; Buti, S.; Camisa, R.; Brighenti, M.; Lazzarelli, S.; Mazza, G.; Passalacqua, R.
Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy. Cancers 2014, 6, 2035-2048.
https://doi.org/10.3390/cancers6042035
AMA Style
Bersanelli M, Buti S, Camisa R, Brighenti M, Lazzarelli S, Mazza G, Passalacqua R.
Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy. Cancers. 2014; 6(4):2035-2048.
https://doi.org/10.3390/cancers6042035
Chicago/Turabian Style
Bersanelli, Melissa, Sebastiano Buti, Roberta Camisa, Matteo Brighenti, Silvia Lazzarelli, Giancarlo Mazza, and Rodolfo Passalacqua.
2014. "Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy" Cancers 6, no. 4: 2035-2048.
https://doi.org/10.3390/cancers6042035
APA Style
Bersanelli, M., Buti, S., Camisa, R., Brighenti, M., Lazzarelli, S., Mazza, G., & Passalacqua, R.
(2014). Gefitinib Plus Interleukin-2 in Advanced Non-Small Cell Lung Cancer Patients Previously Treated with Chemotherapy. Cancers, 6(4), 2035-2048.
https://doi.org/10.3390/cancers6042035